Article: Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism

Fibroblastic rheumatism (FR) is a rare disease first described by Chaouat (in Rev Rhum Mal Osteoartic 47:345-351, 1980) and is characterized by a combination of rheumatologic and dermatological manifestations. Rheumatologic features are symmetrical polyarthralgias with joint stiffness, associated with cutaneous nodules and sclerodactyly. Histology shows an increased number of fibroblasts and a marked dermal fibrosis. A large number of treatments have been tried, but all of them have shown an unpredictable effect on FR. We report a Brazilian case of FR showing a good clinical response to methotrexate treatment. This drug may be considered an effective treatment in FR.

Citing Articles

Fibroblastic rheumatism: an uncommon arthritis. A case-based review.

Pieta A, Zioga A, Skalkou A, Venetsanopoulou A, Drosos A, Voulgari P Rheumatol Int. 2021; 42(6):1097-1103.

PMID: 34611730 DOI: 10.1007/s00296-021-05004-0.

References

1.

Schiavon F, Punzi L, Todesco S . Fibroblastic rheumatism: a fifteen-year followup study. Arthritis Rheum. 1998; 41(4):759-60. DOI: 10.1002/1529-0131(199804)41:4<759::AID-ART39>3.0.CO;2-Y. View

2.

FORTIER-BEAULIEU M, Thomine E, Boullie M, Le Loet X, Lauret P, HEMET J . New electron microscopic findings in a case of multicentric reticulohistiocytosis. Long spacing collagen inclusions. Am J Dermatopathol. 1993; 15(6):587-9. DOI: 10.1097/00000372-199312000-00014. View

3.

Colonna L, Barbieri C, Di Lella G, Zambruno G, Annessi G, Puddu P . Fibroblastic rheumatism: a case without rheumatological symptoms. Acta Derm Venereol. 2002; 82(3):200-3. DOI: 10.1080/00015550260132505. View

4.

Fam A, Hanna W, Mak V, Assaad D . Fibroblastic rheumatism: clinical and histologic evolution of cutaneous manifestations. J Rheumatol. 1998; 25(11):2261-6. View

5.

Cantwell Jr A, Rowe L, Kelso D . Nodular scleroderma and pleomorphic acid-fast bacteria. Arch Dermatol. 1980; 116(11):1283-90. View

6.

Vittecoq O, Mejjad O, Da Silva F, Joly P, Thomine E, Lauret P . Preliminary experience with low-dose methotrexate in fibroblastic rheumatism. Arthritis Rheum. 1996; 39(12):2070-3. DOI: 10.1002/art.1780391218. View

7.

Haraoui B, Pelletier J, Cloutier J, Faure M, Martel-Pelletier J . Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum. 1991; 34(2):153-63. DOI: 10.1002/art.1780340205. View

8.

Meyer F, Yaron I, Mashiah V, Yaron M . Methotrexate inhibits proliferation but not interleukin 1 stimulated secretory activities of cultured human synovial fibroblasts. J Rheumatol. 1993; 20(2):238-42. View

9.

Du Toit R, Schneider J, Whitelaw D . Fibroblastic rheumatism. J Clin Rheumatol. 2006; 12(4):201-3. DOI: 10.1097/01.rhu.0000231383.50323.b5. View

10.

Ostlere L, Stevens H, Jarmulowicz M, Higgens C, Black C, Rustin M . Fibroblastic rheumatism. Clin Exp Dermatol. 1994; 19(3):268-70. DOI: 10.1111/j.1365-2230.1994.tb01185.x. View

11.

Rety F, Tayebjee O, Servettaz A, Godmer P, Le Van An J, Laredo J . Radiological bone lesions in fibroblastic rheumatism; case report. Presse Med. 2007; 36(3 Pt 1):432-6. DOI: 10.1016/j.lpm.2006.11.010. View

12.

Crouzet J, Amouroux J, Duterque M, Halmagrand N, Beraneck L, Guillien P . [Fibroblastic rheumatism. A case with study of synovial histology]. Rev Rhum Mal Osteoartic. 1982; 49(6):469-72. View

Good Clinical Response to Methotrexate Treatment in a Patient with Fibroblastic Rheumatism